Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2022 | The outcomes of patients with primary refractory and relapsed acute leukemia

Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, comments on the outcomes of patients with primary refractory and relapsed acute leukemia. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.